Search results
Bansal Wire IPO Oversubscribed 59 Times on Strong Demand | India Infoline
India Infoline· 3 days agoThe company's ₹745-Crore public offering got bids for more than 67 Crore equity shares, outnumbering the offer size of 2.14 Crore equity shares by 59.27 times.
Latest Market News Today Live Updates July 5, 2024: Gold Prices Today: Yellow metal hits one-month...
Livemint· 4 days agoLatest Market News Today Live Updates: Follow Mint's market blog for real-time updates on your...
Bain-backed Emcure Pharma attracts bids worth $11 bn in IPO
VCCircle· 4 days agoVCCircle is India leading source Latest Indian Financial News,Startup Funding,Real Estate,Funding...
Bansal Wire IPO subscribed 31x on final day as QIBs rush in
CNBC Awaaz· 4 days agoAhead of the public issue, Bansal Wire raised Rs 223.5 crore from anchor investors, including SBI ...
Emcure Pharma IPO day 3: Issue subscribed 5x so far, QIB portion booked fully
CNBC Awaaz· 4 days agoSeveral mutual fund houses, including SBI, HDFC, ICICI Prudential, Whiteoak Capital, Aditya Birla...
Mazagon Dock m-cap tops Rs 1 lakh crore - The Economic Times
The Economic Times· 4 days agoShares of two other shipbuilding companies Cochin Shipyard and Garden Reach Shipbuilders & Engineers...
Short Call: Mutual fund investors chase momentum; capex cycle, Lupin, ITC, Persistent, Inox Wind in...
CNBC Awaaz· 4 days ago“Opportunities come infrequently. When it rains gold, put out the bucket, not the thimble.” Warren...
Motilal Oswal MF’s Defence Index Fund garners Rs 1,676 crore in NFO; highest ever for equity index ...
CNBC Awaaz· 5 days agoThe open-ended fund tracking the total returns of the Nifty India Defence Index saw participation by...
IDBI Bank Summary: Latest Updates and Details | India Infoline
India Infoline· 5 days agoIDBI Bank Ltd Summary: Check out the latest management information and corporate updates of IDBI Bank at India Infoline
Emcure Pharma IPO Day 2: Issue subscribed 2x; NIIs lead from the front
CNBC Awaaz· 5 days agoBrokerages have positively viewed Emcure Pharma's IPO, considering the public offer fairly priced...